Find out more about this year’s Open Access Week, themed ‘It matters how we open knowledge: building structural equity’.
Emma Bagshaw, Mark Larkin and Sam Llewellyn from Vitaccess and Fulvio Baggi, Director of The European Myasthenia Gravis Association discuss the lifecycle of creating collaborative digital patient registries and taking them through to the publications.
A new guide provides practical advice on how to increase patient engagement and involvement at every stage of their development.
The suggestion that preprints could replace traditional journals has been debated. Dr Haseeb Irfanullah provides arguments against this view.
Laurie Myers and Stacy Robison discuss the importance of health literacy in equity, diversity, and inclusion.
Learn how a dataset of nearly half a million researchers can be used to reduce bias and increase equity.
Research from higher-status institutions and countries is postulated to receive more favourable peer review. A recent article suggests this may not be the case.
How can pharma unlock the potential of social media? A recent article from EMWA’s Medical Writing journal discusses potential applications.
ISMPP West 2021 is a LIVE IN-PERSON meeting on October 21-22, 2021, in Irvine, CA, plus a VIRTUAL Encore Event on October 28, 2021! Register now!
Read about their call to action for the pharmaceutical industry to increase sharing of clinical trial data.
David Barrett continues a discussion with Rob Matheis on how medical congresses can deliver value and opportunities for everyone.
Creators of Industry Voice share tips on how to leverage video content to generate discussion among experts, engage viewers, and build brand value.
Find out what’s in the new CONSORT-ROUTINE checklist for randomised controlled trials using cohorts and routinely collected data.
Why loss of confidence in previously published findings does not necessarily lead to self-correction of the scientific record
A new study looks at why researchers may question their past conclusions and how likely they are to disclose this publicly.
Avishek Pal discusses the development and launch of the ISMPP Authorship Algorithm.
How are medical societies innovating in the face of a changing medical conference landscape? David Barrett (CEO of the American Society of Gene & Cell Therapy) spoke with Rob Matheis to explain.